These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19972797)

  • 21. First case series on the use of imiquimod for morphoea.
    Dytoc M; Ting PT; Man J; Sawyer D; Fiorillo L
    Br J Dermatol; 2005 Oct; 153(4):815-20. PubMed ID: 16181467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life in morphoea.
    Klimas NK; Shedd AD; Bernstein IH; Jacobe H
    Br J Dermatol; 2015; 172(5):1329-37. PubMed ID: 25483169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postirradiation linear morphoea.
    Akay BN; Sanli H; Heper AO
    Clin Exp Dermatol; 2010 Jun; 35(4):e106-8. PubMed ID: 19874351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Collagen metabolism in systemic scleroderma].
    Lebedev DA
    Vopr Med Khim; 1978; 24(6):789-95. PubMed ID: 734979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of linear morphoea mistaken for reflex sympathetic dystrophy.
    Thng ST; Wong K
    Singapore Med J; 2013 Mar; 54(3):e50-2. PubMed ID: 23546034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using the Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) to classify morphoea by severity and identify clinically significant change.
    Teske NM; Jacobe HT
    Br J Dermatol; 2020 Feb; 182(2):398-404. PubMed ID: 31049928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of dendritic cell populations using a revised histological staging of morphoea.
    Gilmour TK; Wilkinson B; Breit SN; Kossard S
    Br J Dermatol; 2000 Dec; 143(6):1183-92. PubMed ID: 11122019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.
    Antiga E; Quaglino P; Bellandi S; Volpi W; Del Bianco E; Comessatti A; Osella-Abate S; De Simone C; Marzano A; Bernengo MG; Fabbri P; Caproni M
    Br J Dermatol; 2010 May; 162(5):1056-63. PubMed ID: 20105169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiphospholipid antibody in localised scleroderma.
    Sato S; Fujimoto M; Hasegawa M; Takehara K
    Ann Rheum Dis; 2003 Aug; 62(8):771-4. PubMed ID: 12860735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, histological and high-frequency ultrasonographic evaluation (50 MHz) of morphoea treated with ultraviolet A1 phototherapy.
    Arisi M; Lorenzi L; Incardona P; Fusano M; Zanca A; Rossi MT; Tomasi C; Calzavara-Pinton PG; Venturini M
    Clin Exp Dermatol; 2019 Apr; 44(3):270-276. PubMed ID: 29974485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study of dual-wavelength (532 and 633 nm) laser Doppler imaging and infrared thermography of morphoea.
    Moore TL; Vij S; Murray AK; Bhushan M; Griffiths CE; Herrick AL
    Br J Dermatol; 2009 Apr; 160(4):864-7. PubMed ID: 19067705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disabling pansclerotic and plaque morphoea.
    Iqbal MP; Bajaj DR
    J Coll Physicians Surg Pak; 2007 Aug; 17(8):495-6. PubMed ID: 17785130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of calcipotriol on lesional fibroblasts from patients with active morphoea.
    Bottomley WW; Jutley J; Wood EJ; Goodfield MD
    Acta Derm Venereol; 1995 Sep; 75(5):364-6. PubMed ID: 8615053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased central cornea thickness in localized scleroderma (morphoea).
    Serup J; Serup L
    Metab Pediatr Syst Ophthalmol (1985); 1985; 8(2-3):11-4. PubMed ID: 3870939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphoea with prominent plasma cell endoneuritis.
    Singh M; Farquharson N; Owen C; Howat AJ; Singh S; Francis N; Calonje E
    Clin Exp Dermatol; 2017 Mar; 42(2):196-199. PubMed ID: 28052367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphoea of the breast in a young girl.
    Weinberg JM; Russo M; Hirsch RJ; Don PC
    Clin Exp Dermatol; 2001 Sep; 26(6):497-8. PubMed ID: 11678873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bullous morphoea: a retrospective study.
    Venturi M; Pinna AL; Pilloni L; Atzori L; Ferreli C; Rongioletti F
    Clin Exp Dermatol; 2017 Jul; 42(5):532-535. PubMed ID: 28543394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphoea profunda and its relationship to eosinophilic fasciitis.
    Wlodek C; Korendowych E; McHugh N; Lovell CR
    Clin Exp Dermatol; 2018 Apr; 43(3):306-310. PubMed ID: 29277925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid response to abatacept in treatment-resistant pansclerotic morphoea.
    Attard M; O'Kane D
    Clin Exp Dermatol; 2022 Apr; 47(4):755-757. PubMed ID: 34798687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood flow of morphoea plaques as measured by laser-Doppler flowmetry.
    Serup J; Kristensen JK
    Arch Dermatol Res; 1984; 276(5):322-5. PubMed ID: 6237619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.